Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early phase 2 trial of E6011 in active Crohn's disease
jRCT2080224078Phase 2Completed
- Sponsor
- EA Pharma Co., Ltd.
- Start
- Oct 2018
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
01
Overview
Phase 2, randomised trial in Crohn's disease comparing E6011 arm with Placebo arm (2 arms). Started Oct 2018; status: completed.
02
Drugs
quetmolimab
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on jRCT2080224078.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224078.